What is DN4 Neuropathic Pain Score?
▾
The DN4 (Douleur Neuropathique 4 questions) is a validated clinical questionnaire used to screen for and diagnose neuropathic pain. It was developed by Bouhassira and colleagues in France and published in 2005, and has since been translated and validated in over 20 languages. Neuropathic pain is pain arising as a direct consequence of a lesion or disease affecting the somatosensory nervous system, and it affects approximately 7-8% of the general population. Distinguishing neuropathic from nociceptive pain is essential because the two types require different treatments — neuropathic pain responds poorly to conventional analgesics but may respond to tricyclic antidepressants, SNRIs, gabapentinoids, or topical agents. The DN4 consists of ten items divided into two sections: seven items derived from patient history (symptoms) covering burning sensation, painful cold, electric shocks, tingling, pins and needles, numbness, and itching, and three items derived from clinical examination covering hypoaesthesia to touch, hypoaesthesia to prick (pinprick), and allodynia (pain in response to gentle brushing of the skin). Each positive item scores 1 point, and a total score of 4 or more out of 10 indicates neuropathic pain with a sensitivity of 83% and specificity of 90%. The DN4 is widely used in pain clinics, neurology, oncology, and primary care to guide diagnosis and treatment selection for conditions including diabetic neuropathy, postherpetic neuralgia, cancer pain, and central sensitisation syndromes.
DigiCalcs delivers precision-engineered tools for engineers and STEM professionals.
Formula
▾
DN4 Score = Sum of 10 binary items (each 0 or 1): 7 symptom items (burning, painful cold, electric shocks, tingling, pins-needles, numbness, itching) + 3 examination items (hypoaesthesia to touch, hypoaesthesia to pinprick, allodynia); Score ≥4 = Neuropathic pain likely (sensitivity 83%, specificity 90%)Variable Legend
▾
| Symbol | Name | Unit | Description |
|---|---|---|---|
| DN4 | DN4 Total Score | 0-10 | Sum of all 10 items; ≥4 = neuropathic pain (sensitivity 83%, specificity 90%) |
How to DN4 Neuropathic Pain Score
▾
- 1Ask the patient seven symptom questions about the character of the pain: Is it burning? Does it feel like painful cold? Does it feel like electric shocks? Is it accompanied by tingling, pins and needles, numbness, or itching in the same area? Score 1 for each positive answer.
- 2Proceed to three clinical examination items in or around the painful area.
- 3Test hypoaesthesia to touch using a piece of cotton wool or a wisp of cotton — reduced touch sensation compared to a mirror site scores 1 point.
- 4Test hypoaesthesia to pinprick using a neurological pin or calibrated stick — reduced pain sensation to prick compared to mirror site scores 1 point.
- 5Test for allodynia — lightly brush the painful area with a piece of cotton wool and ask if the brushing feels painful. Any pain response scores 1 point.
- 6Sum all ten binary scores (0 or 1) for the DN4 total.
- 7A score of 4 or more indicates probable neuropathic pain — initiate appropriate pharmacological management and consider specialist referral.
Worked Examples
▾
Initiate neuropathic pain treatment (gabapentin, pregabalin, or duloxetine); optimise glycaemic control
Classic small fibre neuropathy presentation. Score of 7 strongly confirms neuropathic mechanism. First-line pharmacotherapy and podiatry referral appropriate.
Consider lidocaine patches, capsaicin 8% patch, or tricyclic antidepressant for PHN
Near-maximum DN4 score typical of postherpetic neuralgia, one of the most severe and treatment-refractory neuropathic pain syndromes.
Standard analgesics (NSAIDs, paracetamol) appropriate; neuropathic agents not indicated
No neuropathic features. Mechanical nociceptive pain from OA responds to conventional analgesia and physiotherapy, not gabapentinoids.
Central sensitisation may drive symptoms; multidisciplinary pain management team referral
Fibromyalgia and central sensitisation syndromes can score at the DN4 threshold. Treatment overlaps with neuropathic pain management but requires a multidisciplinary approach.
Real-World Applications
▾
Routine screening in diabetic foot clinics to identify peripheral neuropathy with neuropathic pain component warranting pharmacological intervention., representing an important application area for the Neuropathic Pain Dn4 in professional and analytical contexts where accurate neuropathic pain dn4 calculations directly support informed decision-making, strategic planning, and performance optimization
Oncology pain services distinguishing neuropathic cancer pain from nociceptive pain to optimise opioid-sparing adjuvant analgesic use., representing an important application area for the Neuropathic Pain Dn4 in professional and analytical contexts where accurate neuropathic pain dn4 calculations directly support informed decision-making, strategic planning, and performance optimization
Post-operative pain clinics identifying patients who develop chronic post-surgical neuropathic pain (e.g., post-mastectomy, post-thoracotomy)., representing an important application area for the Neuropathic Pain Dn4 in professional and analytical contexts where accurate neuropathic pain dn4 calculations directly support informed decision-making, strategic planning, and performance optimization
Primary care identification of patients with undiagnosed diabetic neuropathy or postherpetic neuralgia who would benefit from specialist referral., representing an important application area for the Neuropathic Pain Dn4 in professional and analytical contexts where accurate neuropathic pain dn4 calculations directly support informed decision-making, strategic planning, and performance optimization
Academic researchers and university faculty use the Neuropathic Pain Dn4 for empirical studies, thesis research, and peer-reviewed publications requiring rigorous quantitative neuropathic pain dn4 analysis across controlled experimental conditions and comparative studies
Special Cases
▾
Mixed Pain Syndromes
In the Neuropathic Pain Dn4, this scenario requires additional caution when interpreting neuropathic pain dn4 results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when neuropathic pain dn4 calculations fall into non-standard territory.
Central Post-Stroke Pain
In the Neuropathic Pain Dn4, this scenario requires additional caution when interpreting neuropathic pain dn4 results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when neuropathic pain dn4 calculations fall into non-standard territory.
Chemotherapy-Induced Peripheral Neuropathy
In the Neuropathic Pain Dn4, this scenario requires additional caution when interpreting neuropathic pain dn4 results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when neuropathic pain dn4 calculations fall into non-standard territory.
Children and Adolescents
In the Neuropathic Pain Dn4, this scenario requires additional caution when interpreting neuropathic pain dn4 results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when neuropathic pain dn4 calculations fall into non-standard territory.
DN4 Score Interpretation
▾
| Score | Interpretation | Clinical Action |
|---|---|---|
| 0-3 | Nociceptive pain likely | Standard analgesics; neuropathic agents not first-line |
| 4-6 | Neuropathic pain probable | First-line neuropathic agents; specialist referral if needed |
| 7-10 | Neuropathic pain highly probable | Confirm diagnosis, initiate treatment, consider specialist pain clinic |
Frequently Asked Questions
▾
What is neuropathic pain and how is it diagnosed using the DN4 questionnaire?
Neuropathic pain is a type of chronic pain caused by damage to the nervous system, and the DN4 questionnaire is a validated tool used to diagnose it. The DN4 consists of 10 items, with 7 related to the description of pain and 3 related to the presence of sensory disturbances. A score of 4 or more out of 10 indicates a high likelihood of neuropathic pain. This questionnaire has been widely used in clinical practice since its development in 2005.
How is the DN4 questionnaire used in practical clinical settings?
The DN4 questionnaire is used by healthcare professionals to screen patients for neuropathic pain. It is typically administered during an initial consultation or as part of a comprehensive pain assessment. Patients are asked to answer the 10 questions, and their responses are scored to determine the likelihood of neuropathic pain. This information can then be used to guide further diagnostic testing and treatment planning.
What are the common DN4 score ranges and what do they indicate?
DN4 scores range from 0 to 10, with higher scores indicating a greater likelihood of neuropathic pain. A score of 0-3 is generally considered low risk, 4-6 is moderate risk, and 7-10 is high risk. For example, a patient with a score of 5 would be considered at moderate risk for neuropathic pain, while a patient with a score of 8 would be considered at high risk.
What are some common mistakes to avoid when using the DN4 questionnaire?
One common mistake is not using the DN4 questionnaire in conjunction with a thorough medical history and physical examination. Another mistake is not considering other potential causes of pain, such as inflammatory or musculoskeletal conditions. Additionally, the DN4 questionnaire should not be used as the sole diagnostic criterion for neuropathic pain; rather, it should be used as one part of a comprehensive diagnostic evaluation. For instance, a score of 4 or more should prompt further investigation, such as laboratory tests or imaging studies.
Can you provide a real-world example of how the DN4 questionnaire is used to diagnose neuropathic pain?
For example, a 45-year-old patient with a history of diabetes presents with complaints of burning pain in their feet. The patient completes the DN4 questionnaire and scores 6 out of 10, indicating a moderate to high likelihood of neuropathic pain. Based on this result, the healthcare provider orders further testing, including nerve conduction studies and electromyography, which confirm the presence of diabetic neuropathy. The patient is then started on a treatment regimen that includes medications to manage their neuropathic pain, such as gabapentin or pregabalin, and lifestyle modifications to manage their diabetes.
Common Mistakes to Avoid
▾
- !Applying DN4 to pain in the absence of known or suspected nervous system lesion — it is a diagnostic tool for neuropathic pain, not a general pain severity scale.
- !Skipping the examination component and using only symptom items, which reduces sensitivity and specificity versus the full tool.
- !Testing allodynia with a firm touch rather than a very light cotton-wool brush — firm stimuli may be painful in nociceptive conditions and falsely score positive.
- !Not comparing sensory findings to a contralateral or unaffected mirror site — hypoaesthesia scoring requires comparison to determine if sensation is genuinely reduced.
- !Using DN4 as a treatment monitoring tool rather than a diagnostic screening instrument.
- !Failing to ask about all seven symptom qualities systematically — busy clinicians often omit itching and painful cold, which are diagnostically relevant.
Pro Tip
Always perform the examination items in a quiet environment with the patient relaxed and clothed appropriately to access the painful area. Contamination from anxiety or anticipation can falsely elevate allodynia scores. Test the mirror site first to establish a sensory baseline before testing the painful area.
Did you know?
When DN4 was published in 2005, it was one of the first neuropathic pain screening tools to include an examination component alongside patient-reported symptoms. The combination of history and examination items dramatically improved discriminant validity compared to symptom-only tools, and the DN4 is now recommended in multiple national and international guidelines for neuropathic pain diagnosis.
References
- ›Bouhassira D et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005.
- ›Treede RD et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008.
- ›NICE Guideline CG173 — Neuropathic pain in adults: pharmacological management (2013).
- ›Finnerup NB et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015.
Have a question about this calculator? Get a detailed answer.
Get Weekly Math Tips
Join 12,000+ subscribers who get calculator tips every week.